Helicobacter pylori attenuates lipopolysaccharide-induced nitric oxide production by murine macrophages

Dah-Yuu Lu1, Chin-Hsin Tang, Chia-Hsian Chang

  • 1Graduate Institute of Neural and Cognitive Sciences, China Medical University, Taichung, Taiwan.

Innate Immunity
|September 20, 2011
PubMed

Insights

Helicobacter pylori evades immune responses by inhibiting nitric oxide (NO) production in macrophages. This suppression of inducible nitric oxide synthase (iNOS) allows the bacteria to survive and persist in the stomach.

Area of Science:

  • Immunology
  • Microbiology
  • Cell Biology

Background:

  • Helicobacter pylori infection is linked to chronic inflammation via pro-inflammatory cytokines and nitric oxide (NO) production.
  • Macrophages produce NO in response to bacterial lipopolysaccharide (LPS), activating inducible nitric oxide synthase (iNOS).
  • H. pylori's mechanism for evading these immune responses is not fully understood.

Purpose of the Study:

  • To investigate how H. pylori evades the host's innate immune response.
  • To elucidate the mechanism by which H. pylori inhibits macrophage NO production.

Main Methods:

  • Utilized a murine model of macrophage infection.
  • Assessed LPS-induced iNOS expression and NO production in macrophages.
  • Analyzed iNOS mRNA and protein levels.
  • Examined the role of the mitogen-activated protein kinase (MAPK) pathway and NF-κB translocation.

Main Results:

  • H. pylori significantly inhibited LPS-induced iNOS expression and NO production in macrophages.
  • This inhibition led to increased H. pylori survival, an effect absent in iNOS-deficient macrophages.
  • H. pylori suppressed iNOS at both transcriptional and post-transcriptional levels, requiring live bacteria.
  • The bacteria downregulated the MAPK pathway and inhibited NF-κB nuclear translocation.

Conclusions:

  • H. pylori employs a novel mechanism to evade innate immunity by suppressing macrophage NO production.
  • This immune evasion strategy involves downregulating the MAPK pathway and NF-κB signaling.
  • These findings reveal how H. pylori establishes persistent infections in the stomach.

Related Concept Videos

Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...